Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HYDROXYCHLOROQUINE SULFATE USP, with a corresponding US DMF Number 31956.
Remarkably, this DMF maintains an Active status since its submission on September 08, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 19, 2017, and payment made on August 30, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II